April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 22, 2025

National Survey Reveals Sex Shift in Alcohol Use

Past-month binge drinking among young adult females in 2021-2023 was higher than males.

Conexiant

April 18, 2025

Intranasal Diazepam Gains Expanded Approval for Pediatric Patients

“Approval of an immediate-use intranasal diazepam treatment that can be given at any time—even while a child is actively seizing—in this young age group is an important advance for the epilepsy community.”

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Misuse Risk Varies by Stimulant Type

Researchers found that one in four U.S. adults using prescription stimulants reported misuse, and nearly one in ten met criteria for stimulant use disorder.

Conexiant

April 09, 2025

Buprenorphine Data Reveal Prescribing Pivot

The rise in extended-release buprenorphine patients signals increasing access and a willingness to adopt this treatment option, researchers noted.

Conexiant

April 02, 2025

Unequal Access Worsens Opioid Crisis for Black Patients

Despite rising opioid overdose rates among Black patients, systemic barriers and unequal access to treatment continue to hinder recovery efforts and worsen outcomes.

KFF Health News

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 27, 2025

FDA Examines Stimulant Use Trends

The FDA reviews rising adult prescription stimulant use, ongoing shortages, and efforts to ensure appropriate access and minimize nonmedical use.

Conexiant